Last reviewed · How we verify
Inactive Placebo Oral Capsule
An inactive placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.
An inactive placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Clinical trial control / comparator (not a therapeutic indication).
At a glance
| Generic name | Inactive Placebo Oral Capsule |
|---|---|
| Also known as | Microcrystalline Cellulose (MCC), Placebo, Placebo, Sugar Pill, Symptom triggered benzodiazepines (e.g., Valium), placebo, Placebo |
| Sponsor | Medical University of South Carolina |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
A placebo is an inert substance used as a control in clinical trials to establish baseline efficacy and safety by comparison with active treatments. Any observed effects are attributed to the placebo effect—psychological and physiological responses to the act of treatment rather than the substance itself. Placebos are essential for blinded study designs to isolate true drug efficacy from expectation-driven outcomes.
Approved indications
- Clinical trial control / comparator (not a therapeutic indication)
Common side effects
Key clinical trials
- Effect of Oral Microbiota on MDRO Decolonization (PHASE1, PHASE2)
- The Acute Effects of Onnit Alpha Brain on Cognition and Mood States (NA)
- New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia (PHASE2)
- PTSD Prevention Using Oral Hydrocortisone (PHASE2)
- Dual Orexin Antagonism and Emotion and Affective Processing Study (PHASE4)
- A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis (NA)
- Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder (PHASE4)
- Efficacy and Safety of Shatavari Root Extract for Premenstrual Syndrome in Women (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Inactive Placebo Oral Capsule CI brief — competitive landscape report
- Inactive Placebo Oral Capsule updates RSS · CI watch RSS
- Medical University of South Carolina portfolio CI